Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Carmell Therapeutics (CTCX)
NASDAQ:CTCX
Carmell Therapeutics (CTCX) Ownership - Who Owns Carmell Therapeutics?
16 Followers
Carmell Therapeutics (CTCX) Ownership Overview
48.50% Insiders
1.25% Mutual Funds
10.09% Other Institutional Investors
40.15% Public Companies and
Individual Investors
The ownership structure of Carmell Therapeutics (CTCX) stock is a mix of institutional, retail and individual investors. Approximately 11.35% of the company’s stock is owned by Institutional Investors, 48.50% is owned by Insiders and 40.15% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| May 31, 2024 | Bought | $1009 | |
| May 28, 2024 | Rajiv Shukla Chairman & Ceo,director, >10% Owner | Bought | $10233 |
| May 22, 2024 | Rajiv Shukla Chairman & Ceo,director, >10% Owner | Bought | $15959 |
| May 22, 2024 | Rajiv Shukla Chairman & Ceo,director, >10% Owner | Bought | $24998 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 692,339 | Institution | 3.33% | 1,772,388 | |
| 170,568 | Institution | 0.82% | 436,654 | |
| 170,006 | Institution | 0.82% | 435,215 | |
| 128,330 | Institution | 0.62% | 328,525 | |
| 90,928 | Institution | 0.44% | 232,776 | |
| 89,014 | Institution | 0.43% | 227,876 | |
| 1,749 | Institution | <0.01% | 4,477 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 170,006 | Institution | 0.82% | 435,215 | |
| 89,014 | Institution | 0.43% | 227,876 | |
| 1,749 | Institution | <0.01% | 4,477 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 168,340 | Institution | 0.81% | 351,831 | |
| 2,228 | Institution | 0.01% | 4,657 |
FAQ
Who Owns Carmell Therapeutics (CTCX)?
According to the latest TipRanks data, approximately 10.09% of the company's stock is held by institutional investors, 48.50% is held by insiders, and 40.15% is held by retail investors.
What percentage of Carmell Therapeutics (CTCX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 10.09% of Carmell Therapeutics (CTCX) stock is held by institutional investors.
What percentage of Carmell Therapeutics (CTCX) stock is held by retail investors?
According to the latest TipRanks data, approximately 40.15% of Carmell Therapeutics (CTCX) stock is held by retail investors.
Who owns the most shares of Carmell Therapeutics (CTCX)?
Robert Henry Lynch owns the most shares of Carmell Therapeutics (CTCX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.